Papers

1

Total Citations

18

H-Index

1

About

Dr. Mengnai Li is a leading orthopedic surgeon-researcher whose work centers on improving outcomes for patients undergoing total hip arthroplasty (THA). His research critically examines the patient experience, revealing that nearly one in five individuals with degenerative joint disease awaiting hip replacement considers their health state worse than death, with pain identified as the primary driver. Dr. Li’s most cited paper, “What’s New in Hip Replacement” (2020, 18 citations), highlights this sobering statistic while also addressing the practical challenge of reducing the burden of complex patient-reported outcome measures (PROMs). By advocating for streamlined assessment tools, his work aims to enhance clinical decision-making and patient-centered care. Dr. Li’s contributions bridge the gap between surgical innovation and the real-world suffering of patients, pushing the field toward more compassionate and efficient preoperative evaluation. His insights are particularly valuable for trainees and clinicians seeking to understand the profound impact of hip disease on quality of life and the ongoing need for accessible, patient-friendly outcome measures.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
What’s New in Hip Replacement
18 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: The Ohio State University Wexner Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago